In our recent paper, we introduce Random Similarity Forest, a machine learning algorithm capable of handling datasets with features of arbitrary data types while retaining each feature's characteristic. As evidenced…
Maria Ancukiewicz19 April 2022
News
MNM Bioscience began as a bioinformatics company that curates data and then builds artificial intelligence-based algorithms, but it is now looking to branch out into oncology drug target discovery. About…
Maria Ancukiewicz15 April 2022
MNM Bioscience Inc. announced that it had filed a provisional patent application, entitled “METHODS AND SYSTEMS FOR PREDICTING THERAPEUTIC RESPONSIVENESS” for Random Similarity Forest (RSF), a classifier that performs a…
Maria Ancukiewicz8 April 2022
We are thrilled to announce that MNM Bioscience received $800 000 funding through Eureka Eurostars for our newest project. Eurostars 3 program was established with the aim to support…
Ania Czastka5 April 2022
With entire genomes at hand, scientists can pinpoint DNA fragments responsible for different cancers and predict patient responses to cancer treatments. However, the sheer volume of whole-genome data makes it…
Katarzyna Cieśla11 February 2022
MNM Biosciences, in co-operation with leading Polish cancer centers, has recently published a breakthrough publication concerning breast cancer diagnostics. The article in Molecular Diagnosis & Therapy presents an innovative method…
Katarzyna Cieśla21 December 2021
In the Perspective work-issued today, we highlight the possible genetic background of COVID-19 interindividual variability, ranging from asymptomatic infection to life-threatening disease. Despite many international efforts, the genetic and immunological…
Katarzyna Cieśla21 October 2021
Breast cancer (BC) constitutes the most common female malignancy and nowadays molecular classification of subtypes is crucial to estimate a patient’s prognosis and administer appropriate treatment. It allows tailoring therapeutic…
Maria Ancukiewicz3 May 2022
MNM Bioscience presents its participation in the fifth DNA Repair/Replication Structures & Cancer conference (27 Apr 2022 - 01 May 2022), where speakers will focus on presenting the structural and…
Maria Ancukiewicz25 April 2022
Since our world is changing rapidly, especially biotech and healthcare fields must actively adapt to those alterations. We can all learn from leaders in other industries to understand how our…
Katarzyna Cieśla9 February 2022
Almost a week has passed since the Europe Biobank Week 2021, and yet we are still impressed! We have attended great lectures, in which the speakers approached the topic of…
Katarzyna Cieśla22 November 2021
BioFuture is a Conference, where pioneers, innovators and entrepreneurs gather to be part of the discussions that will shape and transform the future of healthcare. One can say that the…
Katarzyna Cieśla19 October 2021
MNM Diagnostics has developed a unique AI-powered platform allowing for the rapid development of genome-based biomarkers providing an accurate prediction of the treatment outcomes for cancer patients. To date, we…
Katarzyna Tylak14 May 2021